364 filings
Page 6 of 19
6-K
2js7cuq
28 Jun 19
BioLineRx Announces Change in Ratio of American
4:01pm
6-K
wde0sq193q74d418zuta
28 May 19
Current report (foreign)
7:04am
6-K
x9f8vv9hwn2cj8
14 May 19
BioLineRx Reports First Quarter 2019 Financial Results
7:00am
6-K
sqf2ba3pgb
7 May 19
Current report (foreign)
7:00am
6-K
jpd5ba2qw csm09ouv
28 Mar 19
BioLineRx Reports Year End 2018 Financial Results
7:00am
6-K
pxhvi3sk3lud
27 Mar 19
BioLineRx Announces Successful Engraftment Data
7:01am
6-K
xce7i4s0t
7 Feb 19
As Representative of the several Underwriters
12:00pm
6-K
36vtakxx9 2suzj9v
5 Feb 19
BioLineRx Announces Pricing of $15.4 Million Underwritten Public Offering of its American Depositary Shares and Warrants
9:00am
6-K
3z1exr
4 Feb 19
Current report (foreign)
4:30pm
6-K
7sobxje
4 Feb 19
BioLineRx Receives Orphan Drug Designation from the FDA
7:00am
6-K
s4swin6
11 Dec 18
BioLineRx Announces Initiation of Triple Combination Arm of
7:00am
6-K
pf1d1ei9eo6 6dytp
4 Dec 18
Current report (foreign)
7:00am
6-K
abht71w0mzwgte3vc4yv
20 Nov 18
BioLineRx Announces Receipt of FDA Biological Product
7:00am
6-K
03oyu8wvtedy7 9y9
8 Nov 18
BioLineRx Reports Significant Progress Across Oncology
7:00am
6-K
0tnrz c8y00dop5m5w
22 Oct 18
Current report (foreign)
7:00am
6-K
85vn8s4y4lm3tzbpkv
19 Oct 18
BioLineRx Presents Top-Line Results from
7:00am
6-K
dnk8r7
11 Oct 18
Current report (foreign)
7:00am
6-K
irf15r5yv s6zulmi
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
6-K
5v5cur k36wr5v
13 Aug 18
BioLineRx Reports Second Quarter 2018 Financial Results
7:01am
6-K
jbvz4h
7 Aug 18
BioLineRx Announces Positive Results of Lead-in Period
7:00am